Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Formula of gardenia jasminoides granules

A formulation and granule technology, which is applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, bulk delivery, etc., to achieve the effects of avoiding early maturation, delaying premature development, delaying closure time and ovarian ovulation time

Inactive Publication Date: 2021-10-19
杨丽珍
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, for the treatment of this type of syndrome, most doctors in modern medicine cannot accurately differentiate the syndrome, and still use Zhibai Dihuang Pills for treatment, and the treatment effect is counterproductive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formula of gardenia jasminoides granules

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Such as figure 1 As shown, the present invention provides a Zhizao granule formula, the crude drug amount of the formula is: Bupleurum 6g, Gardenia 10g, Scutellaria baicalensis 10g, Cortex Moutan 6g, Curcuma 10g, Rhizoma Cyperi 10g, Trichosanthes 10g, Prunella vulgaris 10g, Fritillaria 10g, litchi core 10g, Atractylodes macrocephala 10g, tangerine peel 6g, pinellia chinensis 6g and peony root 10g.

Embodiment 2

[0019] Such as figure 1 As shown, the present invention provides a Zhizao granule formula, and the crude drug amount of the formula is: Bupleurum 3g, Gardenia 7g, Scutellaria baicalensis 7g, Moutan cortex 3g, Curcuma 7g, Cyperus cyperi 7g, Trichosanthes 7g, Prunella vulgaris 7g, Fritillaria 7g, litchi core 7g, Atractylodes macrocephala 7g, tangerine peel 3g, pinellia chinensis 3g and peony root 7g.

Embodiment 3

[0021] Such as figure 1 As shown, the present invention provides a Zhizao granule formula, the crude drug amount of the formula is: Bupleurum 9g, Gardenia 13g, Scutellaria baicalensis 13g, Cortex Moutan 9g, Curcuma 13g, Rhizoma Cyperi 13g, Trichosanthes 13g, Prunella vulgaris 13g, Fritillaria 13g, litchi core 13g, Atractylodes macrocephala 13g, tangerine peel 9g, pinellia 9g and peony root 13g.

[0022] Specifically, Bupleurum relieving stagnation of the liver, and gardenia clearing away the liver-fire, so that the liver-qi can be organized and the pent-fire can be cleared, and they are the king medicines. Scutellaria baicalensis is bitter and cold, clearing heat and purging fire; Cortex Moutan cools blood and activates blood; Curcuma returns to liver, gallbladder, and heart meridian, regulates qi and activates blood, soothes liver and relieves stagnation; Rhizoma cyperus can circulate qi, dissolve six stagnations, and enter the blood Divide, clear the veins; all medicines ar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a formula of gardenia jasminoides granules. The formula comprises the following raw medicinal materials: 3 to 9 grams of radix bupleuri, 7 to 13 grams of fructus gardeniae, 7 to 13 grams of radix scutellariae, 3 to 9 grams of cortex moutan, 7 to 13 grams of radix curcumae, 7 to 13 grams of rhizoma cyperi, 7 to 13 grams of fructus trichosanthis, 7 to 13 grams of spica prunellae, 7 to 13 grams of bulbus fritillariae thunbergii, 7 to 13 grams of semen litchi, 7 to 13 grams of rhizoma atractylodis macrocephalae, 3 to 9 grams of pericarpium citri reticulatae, 3 to 9 grams of rhizoma pinelliae preparata and 7 to 13 grams of radix paeoniae alba. The formula of the gardenia jasminoides granules can be used for treating idiopathic central precocious puberty, delaying premature development of a second sexual character and avoiding early maturity of bones and sexual organs, so that the treatment purposes of delaying the closing time of epiphysis and ovulation time of ovaries and improving the expected height and fertility function of sick children are achieved.

Description

technical field [0001] The invention relates to the field of pharmaceutical formulations, in particular to a formulation of Zhizao granules. Background technique [0002] Precocious puberty refers to the appearance of secondary sexual characteristics before the age of 8 in girls and 9 years in boys. In recent years, with the improvement of material life and nutritional conditions, and the aggravation of chemical pollution, the clinical incidence of precocious puberty has increased year by year. It is a frequently-occurring disease and a common disease in children's endocrinology. Idiopathic central precocious puberty is a common type of precocious puberty, with an incidence of more than 92% of all precocious children. The main hypothalamus-pituitary-gonadal axis is prematurely activated, and the secretion of gonadotropin-releasing hormone pulses is enhanced, stimulating The synthesis and release of follicle-stimulating hormone and luteinizing hormone, FSH and LH stimulate t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P3/00A61P5/00A61K9/16
CPCA61K36/233A61K36/744A61K36/539A61K36/71A61K36/65A61K36/9066A61K36/8905A61K36/428A61K36/536A61K36/8966A61K36/77A61K36/284A61K36/752A61K36/8888A61K9/16A61P3/00A61P5/00A61K2300/00
Inventor 杨丽珍
Owner 杨丽珍
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products